Don't Lose Sight Of Opthalmic Injectables' Regulatory Complexity

A recent panel discussion with experts from West Pharmaceutical Services’ Technical Customer Support Team discussed evolving regulatory guidance surrounding intravitreal therapies: injectable drugs delivered directly into the eye. Due to the high-risk of sight-related complications from intravitreal injections, these injectable drug therapies are highly scrutinized by regulators.

Global regulatory agencies also are working to harmonize their standards, providing developers of ophthalmic therapies with greater clarity on expectations from components sourcing and production to final packaging. The event’s panelists sorted thought he complexities and nuance of these rules during a post-webinar discussion with attendees.